Concepts (319)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Switzerland | 39 | 2021 | 2738 | 2.19 | Why? |
| Caffeine | 3 | 2018 | 67 | 1.54 | Why? |
| Internal Medicine | 4 | 2018 | 557 | 1.40 | Why? |
| Vascular Stiffness | 3 | 2019 | 264 | 1.28 | Why? |
| Socioeconomic Factors | 13 | 2021 | 8495 | 1.17 | Why? |
| General Practice | 3 | 2018 | 718 | 1.08 | Why? |
| Feeding Behavior | 6 | 2018 | 1909 | 1.07 | Why? |
| Mammography | 2 | 2018 | 410 | 1.05 | Why? |
| Diet | 6 | 2018 | 2052 | 1.05 | Why? |
| Smoke-Free Policy | 1 | 2018 | 52 | 0.68 | Why? |
| Early Detection of Cancer | 3 | 2018 | 1956 | 0.67 | Why? |
| Noise | 1 | 2018 | 194 | 0.61 | Why? |
| Men's Health | 1 | 2016 | 80 | 0.60 | Why? |
| Social Class | 3 | 2020 | 1360 | 0.60 | Why? |
| Energy Intake | 2 | 2018 | 323 | 0.59 | Why? |
| Language | 2 | 2018 | 655 | 0.59 | Why? |
| Diet Surveys | 5 | 2018 | 152 | 0.58 | Why? |
| Alcoholic Beverages | 1 | 2017 | 186 | 0.54 | Why? |
| Iatrogenic Disease | 1 | 2017 | 304 | 0.53 | Why? |
| Spatio-Temporal Analysis | 1 | 2020 | 1182 | 0.53 | Why? |
| Precision Medicine | 3 | 2018 | 1477 | 0.50 | Why? |
| Circadian Rhythm | 1 | 2018 | 607 | 0.46 | Why? |
| Physical Examination | 2 | 2017 | 755 | 0.44 | Why? |
| Family Characteristics | 3 | 2021 | 2551 | 0.44 | Why? |
| Mass Screening | 3 | 2017 | 8005 | 0.41 | Why? |
| Breast Neoplasms | 2 | 2018 | 3633 | 0.39 | Why? |
| Smoking Cessation | 1 | 2018 | 826 | 0.38 | Why? |
| Sodium, Dietary | 3 | 2019 | 45 | 0.38 | Why? |
| Heart Ventricles | 1 | 2018 | 1139 | 0.38 | Why? |
| Policy | 1 | 2017 | 1372 | 0.37 | Why? |
| Nutrition Policy | 3 | 2018 | 132 | 0.37 | Why? |
| Uterine Cervical Neoplasms | 1 | 2017 | 842 | 0.36 | Why? |
| Muscle Strength | 3 | 2019 | 317 | 0.34 | Why? |
| Life Style | 2 | 2018 | 2708 | 0.34 | Why? |
| Intention | 1 | 2017 | 1380 | 0.34 | Why? |
| Nutritional Status | 2 | 2018 | 1403 | 0.34 | Why? |
| Cluster Analysis | 3 | 2021 | 3001 | 0.33 | Why? |
| Vulnerable Populations | 1 | 2021 | 3099 | 0.31 | Why? |
| Gonadal Steroid Hormones | 2 | 2019 | 328 | 0.30 | Why? |
| Potassium | 2 | 2019 | 325 | 0.30 | Why? |
| Aging | 5 | 2019 | 3581 | 0.29 | Why? |
| Antibodies, Viral | 8 | 2021 | 51949 | 0.29 | Why? |
| Aortic Aneurysm, Abdominal | 1 | 2008 | 155 | 0.29 | Why? |
| Smoking | 2 | 2019 | 3358 | 0.29 | Why? |
| Alcohol Drinking | 1 | 2017 | 1663 | 0.29 | Why? |
| Independent Living | 4 | 2019 | 842 | 0.28 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.28 | Why? |
| Genomics | 1 | 2016 | 3118 | 0.27 | Why? |
| Glycopeptides | 2 | 2017 | 199 | 0.27 | Why? |
| Middle Aged | 47 | 2021 | 270681 | 0.27 | Why? |
| Occupations | 3 | 2018 | 733 | 0.26 | Why? |
| Immunoglobulin G | 5 | 2021 | 21571 | 0.25 | Why? |
| Blood Pressure | 4 | 2018 | 2198 | 0.25 | Why? |
| Cross-Sectional Studies | 19 | 2021 | 53120 | 0.25 | Why? |
| Educational Status | 3 | 2018 | 1451 | 0.24 | Why? |
| Adult | 37 | 2021 | 244371 | 0.24 | Why? |
| Prevalence | 8 | 2021 | 25773 | 0.23 | Why? |
| Female | 50 | 2021 | 380317 | 0.23 | Why? |
| Aged | 39 | 2021 | 215776 | 0.23 | Why? |
| Muscle, Skeletal | 2 | 2019 | 915 | 0.23 | Why? |
| Heart Diseases | 1 | 2018 | 3503 | 0.22 | Why? |
| Sample Size | 2 | 2021 | 518 | 0.22 | Why? |
| Diet, Fat-Restricted | 2 | 2018 | 15 | 0.21 | Why? |
| Seroepidemiologic Studies | 6 | 2021 | 10017 | 0.21 | Why? |
| Humans | 71 | 2021 | 930598 | 0.21 | Why? |
| Apolipoprotein A-I | 1 | 2021 | 148 | 0.21 | Why? |
| Male | 47 | 2021 | 367725 | 0.21 | Why? |
| Dietary Carbohydrates | 2 | 2017 | 64 | 0.21 | Why? |
| Sex Factors | 7 | 2020 | 11014 | 0.20 | Why? |
| Income | 3 | 2018 | 1564 | 0.20 | Why? |
| Health Surveys | 4 | 2021 | 2841 | 0.20 | Why? |
| Glomerular Filtration Rate | 4 | 2019 | 1262 | 0.20 | Why? |
| Dietary Fats | 2 | 2017 | 96 | 0.20 | Why? |
| Life History Traits | 1 | 2019 | 20 | 0.20 | Why? |
| Dietary Proteins | 2 | 2017 | 112 | 0.19 | Why? |
| Ambulatory Care | 3 | 2021 | 4947 | 0.19 | Why? |
| Extracellular Matrix Proteins | 1 | 2019 | 95 | 0.19 | Why? |
| Frail Elderly | 3 | 2020 | 1427 | 0.19 | Why? |
| Calcium-Binding Proteins | 1 | 2019 | 121 | 0.19 | Why? |
| Renal Artery | 1 | 2019 | 66 | 0.19 | Why? |
| Geriatric Assessment | 5 | 2020 | 1372 | 0.19 | Why? |
| Healthcare Disparities | 1 | 2017 | 3893 | 0.19 | Why? |
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2017 | 21 | 0.18 | Why? |
| Blood Flow Velocity | 1 | 2019 | 193 | 0.18 | Why? |
| Healthy Aging | 1 | 2020 | 147 | 0.18 | Why? |
| Potassium, Dietary | 1 | 2017 | 10 | 0.18 | Why? |
| Kidney | 5 | 2019 | 3648 | 0.18 | Why? |
| Calcium, Dietary | 1 | 2017 | 21 | 0.17 | Why? |
| Cytochrome P-450 CYP2A6 | 1 | 2016 | 4 | 0.17 | Why? |
| Cytochrome P-450 CYP1A2 | 1 | 2016 | 25 | 0.17 | Why? |
| Renal Elimination | 1 | 2017 | 62 | 0.17 | Why? |
| Sodium | 1 | 2019 | 309 | 0.17 | Why? |
| Electrolytes | 1 | 2017 | 103 | 0.17 | Why? |
| Cadmium | 1 | 2018 | 105 | 0.17 | Why? |
| Dietary Fiber | 1 | 2017 | 73 | 0.16 | Why? |
| Patient Compliance | 2 | 2018 | 1468 | 0.16 | Why? |
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 96 | 0.16 | Why? |
| Gene-Environment Interaction | 1 | 2017 | 127 | 0.16 | Why? |
| Multiple Chronic Conditions | 1 | 2017 | 115 | 0.16 | Why? |
| Multivariate Analysis | 2 | 2018 | 5440 | 0.15 | Why? |
| Mendelian Randomization Analysis | 1 | 2018 | 317 | 0.15 | Why? |
| Post-Exposure Prophylaxis | 1 | 2020 | 472 | 0.15 | Why? |
| Polycystic Kidney Diseases | 1 | 2014 | 6 | 0.15 | Why? |
| Arginine Vasopressin | 1 | 2014 | 14 | 0.15 | Why? |
| Young Adult | 14 | 2021 | 93724 | 0.14 | Why? |
| Receptors, Aryl Hydrocarbon | 1 | 2016 | 152 | 0.14 | Why? |
| Hyperlipoproteinemia Type II | 1 | 2017 | 123 | 0.14 | Why? |
| Principal Component Analysis | 1 | 2017 | 689 | 0.14 | Why? |
| Developed Countries | 1 | 2018 | 500 | 0.14 | Why? |
| Seasons | 2 | 2017 | 4071 | 0.14 | Why? |
| Delivery of Health Care | 3 | 2021 | 15909 | 0.13 | Why? |
| Quality of Life | 4 | 2019 | 9820 | 0.13 | Why? |
| Homeostasis | 1 | 2017 | 582 | 0.13 | Why? |
| Age Distribution | 2 | 2020 | 3567 | 0.12 | Why? |
| Nutrition Assessment | 1 | 2017 | 527 | 0.12 | Why? |
| Neoplasms | 2 | 2018 | 17251 | 0.12 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.12 | Why? |
| Europe | 6 | 2020 | 12702 | 0.12 | Why? |
| Urban Health | 1 | 2016 | 382 | 0.12 | Why? |
| Vitamin D | 2 | 2018 | 2904 | 0.12 | Why? |
| Spatial Analysis | 1 | 2018 | 878 | 0.12 | Why? |
| Renal Insufficiency | 1 | 2019 | 810 | 0.12 | Why? |
| Insulin Resistance | 1 | 2017 | 669 | 0.12 | Why? |
| Respiratory Function Tests | 1 | 2019 | 1755 | 0.12 | Why? |
| Ethanol | 1 | 2017 | 533 | 0.11 | Why? |
| Fatigue | 3 | 2021 | 2479 | 0.11 | Why? |
| Antigens, CD | 1 | 2016 | 984 | 0.11 | Why? |
| Activities of Daily Living | 2 | 2017 | 1530 | 0.11 | Why? |
| Immunoglobulins | 1 | 2016 | 811 | 0.11 | Why? |
| Disabled Persons | 2 | 2019 | 1152 | 0.10 | Why? |
| Adolescent | 11 | 2021 | 86841 | 0.10 | Why? |
| Autoantibodies | 1 | 2021 | 2094 | 0.10 | Why? |
| Medical Informatics | 1 | 2017 | 648 | 0.10 | Why? |
| General Practitioners | 1 | 2017 | 568 | 0.10 | Why? |
| Iron | 1 | 2015 | 619 | 0.10 | Why? |
| Serologic Tests | 2 | 2020 | 4359 | 0.10 | Why? |
| Hypertension | 4 | 2019 | 8895 | 0.09 | Why? |
| Dyslipidemias | 1 | 2016 | 791 | 0.09 | Why? |
| Heart Rate | 1 | 2018 | 1527 | 0.09 | Why? |
| Age Factors | 6 | 2020 | 21039 | 0.09 | Why? |
| Longitudinal Studies | 6 | 2020 | 9893 | 0.09 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.09 | Why? |
| Frailty | 1 | 2020 | 1432 | 0.09 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2018 | 3607 | 0.09 | Why? |
| Alzheimer Disease | 1 | 2018 | 1020 | 0.09 | Why? |
| Hand Strength | 2 | 2019 | 202 | 0.09 | Why? |
| Immunoassay | 2 | 2021 | 4485 | 0.09 | Why? |
| Membrane Glycoproteins | 1 | 2016 | 2273 | 0.09 | Why? |
| Body Mass Index | 2 | 2018 | 4306 | 0.08 | Why? |
| Aortic Rupture | 1 | 2008 | 64 | 0.08 | Why? |
| Long QT Syndrome | 1 | 2017 | 1047 | 0.08 | Why? |
| Employment | 1 | 2018 | 1754 | 0.08 | Why? |
| Self Report | 4 | 2021 | 3802 | 0.08 | Why? |
| Health Status | 2 | 2019 | 3259 | 0.08 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 1261 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Health Status Disparities | 3 | 2020 | 4072 | 0.08 | Why? |
| Aged, 80 and over | 14 | 2021 | 88759 | 0.08 | Why? |
| Social Determinants of Health | 1 | 2018 | 1757 | 0.08 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.08 | Why? |
| Surveys and Questionnaires | 6 | 2018 | 43792 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Urinalysis | 2 | 2019 | 218 | 0.07 | Why? |
| Home Care Services | 1 | 2017 | 1351 | 0.07 | Why? |
| Guideline Adherence | 1 | 2018 | 2309 | 0.07 | Why? |
| Child | 8 | 2021 | 70012 | 0.07 | Why? |
| Delivery of Health Care, Integrated | 1 | 2017 | 1549 | 0.07 | Why? |
| Kidney Function Tests | 2 | 2019 | 520 | 0.07 | Why? |
| Vegetables | 2 | 2018 | 340 | 0.07 | Why? |
| Cause of Death | 1 | 2018 | 4823 | 0.07 | Why? |
| Child, Preschool | 4 | 2021 | 36283 | 0.07 | Why? |
| Biomarkers | 5 | 2018 | 23361 | 0.07 | Why? |
| France | 2 | 2017 | 12074 | 0.07 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.07 | Why? |
| Coronary Artery Disease | 1 | 2018 | 2570 | 0.07 | Why? |
| Algorithms | 1 | 2021 | 7346 | 0.06 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.06 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.06 | Why? |
| Glucocorticoids | 1 | 2019 | 4431 | 0.06 | Why? |
| Pandemics | 12 | 2021 | 389249 | 0.06 | Why? |
| Cohort Studies | 7 | 2019 | 36005 | 0.06 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.06 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.06 | Why? |
| Adrenal Cortex Hormones | 1 | 2018 | 6537 | 0.05 | Why? |
| Genome-Wide Association Study | 2 | 2018 | 1648 | 0.05 | Why? |
| Risk Factors | 8 | 2019 | 71621 | 0.05 | Why? |
| Toll-Like Receptor 2 | 1 | 2021 | 198 | 0.05 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.05 | Why? |
| Prospective Studies | 6 | 2021 | 43301 | 0.05 | Why? |
| Cytochrome P450 Family 2 | 1 | 2018 | 4 | 0.05 | Why? |
| Cholestanetriol 26-Monooxygenase | 1 | 2018 | 12 | 0.05 | Why? |
| Muscle Strength Dynamometer | 1 | 2018 | 11 | 0.05 | Why? |
| Cultural Deprivation | 1 | 2018 | 8 | 0.05 | Why? |
| Mineralocorticoids | 1 | 2018 | 4 | 0.05 | Why? |
| Vascular Resistance | 1 | 2019 | 148 | 0.05 | Why? |
| Books | 1 | 2018 | 22 | 0.05 | Why? |
| Pulse Wave Analysis | 1 | 2019 | 221 | 0.05 | Why? |
| Sequence Homology, Amino Acid | 1 | 2021 | 945 | 0.05 | Why? |
| Albuminuria | 1 | 2019 | 164 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2018 | 7330 | 0.05 | Why? |
| Nutritive Value | 1 | 2018 | 100 | 0.04 | Why? |
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2018 | 106 | 0.04 | Why? |
| Life Change Events | 1 | 2020 | 208 | 0.04 | Why? |
| Odds Ratio | 2 | 2021 | 5861 | 0.04 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.04 | Why? |
| Fatty Acids, Monounsaturated | 1 | 2017 | 42 | 0.04 | Why? |
| Registries | 1 | 2018 | 12327 | 0.04 | Why? |
| Outpatients | 2 | 2021 | 3417 | 0.04 | Why? |
| Theobromine | 1 | 2016 | 4 | 0.04 | Why? |
| Cost-Benefit Analysis | 1 | 2008 | 2259 | 0.04 | Why? |
| Fluorescent Antibody Technique | 1 | 2020 | 835 | 0.04 | Why? |
| Prodromal Symptoms | 1 | 2018 | 133 | 0.04 | Why? |
| Theophylline | 1 | 2016 | 39 | 0.04 | Why? |
| Fatty Acids, Unsaturated | 1 | 2017 | 70 | 0.04 | Why? |
| Mental Recall | 1 | 2017 | 77 | 0.04 | Why? |
| Aldosterone | 1 | 2018 | 155 | 0.04 | Why? |
| Exercise | 1 | 2017 | 6771 | 0.04 | Why? |
| Body Height | 1 | 2017 | 100 | 0.04 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.04 | Why? |
| Pedigree | 1 | 2017 | 502 | 0.04 | Why? |
| Ultrasonography, Doppler | 1 | 2019 | 406 | 0.04 | Why? |
| Coffee | 1 | 2016 | 79 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Physical Endurance | 1 | 2017 | 107 | 0.04 | Why? |
| Mobility Limitation | 1 | 2017 | 153 | 0.04 | Why? |
| Inflammation | 1 | 2018 | 13255 | 0.04 | Why? |
| Immune Sera | 1 | 2020 | 884 | 0.04 | Why? |
| Seafood | 1 | 2016 | 103 | 0.04 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.04 | Why? |
| Fishes | 1 | 2016 | 99 | 0.04 | Why? |
| Sensitivity and Specificity | 3 | 2021 | 22971 | 0.04 | Why? |
| Vaccination | 1 | 2020 | 19050 | 0.04 | Why? |
| Depression | 1 | 2019 | 14116 | 0.03 | Why? |
| DNA Mutational Analysis | 1 | 2017 | 581 | 0.03 | Why? |
| Computational Biology | 2 | 2021 | 4514 | 0.03 | Why? |
| Fruit | 1 | 2016 | 313 | 0.03 | Why? |
| Follow-Up Studies | 3 | 2018 | 17020 | 0.03 | Why? |
| Social Environment | 1 | 2017 | 389 | 0.03 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.03 | Why? |
| Russia | 1 | 2017 | 989 | 0.03 | Why? |
| Research Design | 2 | 2020 | 5830 | 0.03 | Why? |
| Area Under Curve | 1 | 2020 | 2564 | 0.03 | Why? |
| Hospital Mortality | 1 | 2017 | 22087 | 0.03 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.03 | Why? |
| Incidental Findings | 1 | 2017 | 487 | 0.03 | Why? |
| Testosterone | 1 | 2018 | 596 | 0.03 | Why? |
| Telephone | 1 | 2021 | 1705 | 0.03 | Why? |
| Confidence Intervals | 1 | 2014 | 744 | 0.03 | Why? |
| Interviews as Topic | 1 | 2021 | 1952 | 0.03 | Why? |
| Reference Values | 1 | 2014 | 795 | 0.03 | Why? |
| Sweden | 1 | 2018 | 1969 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| United States | 1 | 2018 | 46150 | 0.03 | Why? |
| Analysis of Variance | 1 | 2014 | 950 | 0.03 | Why? |
| Public Health | 1 | 2017 | 16359 | 0.03 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.03 | Why? |
| Environment | 1 | 2017 | 769 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Headache | 1 | 2021 | 2257 | 0.03 | Why? |
| Peptide Fragments | 1 | 2021 | 2075 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2016 | 11497 | 0.03 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.03 | Why? |
| New Zealand | 1 | 2017 | 2073 | 0.03 | Why? |
| Housing | 1 | 2018 | 1146 | 0.03 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.03 | Why? |
| Health Behavior | 2 | 2018 | 4449 | 0.02 | Why? |
| Metabolic Syndrome | 1 | 2017 | 810 | 0.02 | Why? |
| Vitamins | 1 | 2018 | 1208 | 0.02 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.02 | Why? |
| Data Collection | 1 | 2019 | 1769 | 0.02 | Why? |
| Perception | 1 | 2020 | 2827 | 0.02 | Why? |
| Peptides | 1 | 2021 | 2513 | 0.02 | Why? |
| Biological Specimen Banks | 1 | 2017 | 1142 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Epitopes | 1 | 2021 | 4113 | 0.02 | Why? |
| Leukocyte Count | 1 | 2018 | 3178 | 0.02 | Why? |
| Hospitals, University | 1 | 2021 | 4173 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Linear Models | 1 | 2014 | 1914 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2021 | 4002 | 0.02 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.02 | Why? |
| Personnel, Hospital | 1 | 2021 | 2273 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Exercise Therapy | 1 | 2015 | 976 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| Software | 1 | 2017 | 2501 | 0.02 | Why? |
| Renal Insufficiency, Chronic | 1 | 2019 | 2654 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2017 | 1962 | 0.02 | Why? |
| Fever | 1 | 2021 | 7795 | 0.02 | Why? |
| Family | 1 | 2018 | 2909 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2014 | 1956 | 0.02 | Why? |
| Olfaction Disorders | 1 | 2021 | 3704 | 0.02 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Disease Management | 1 | 2021 | 6841 | 0.02 | Why? |
| Dietary Supplements | 1 | 2015 | 2251 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| C-Reactive Protein | 1 | 2018 | 7972 | 0.01 | Why? |
| Databases, Factual | 1 | 2017 | 6248 | 0.01 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2020 | 10649 | 0.01 | Why? |
| Retrospective Studies | 3 | 2019 | 105322 | 0.01 | Why? |
| Information Dissemination | 1 | 2017 | 2986 | 0.01 | Why? |
| Chronic Disease | 1 | 2015 | 5139 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Infant, Newborn | 1 | 2021 | 23105 | 0.01 | Why? |
| Internet | 1 | 2017 | 6204 | 0.01 | Why? |
| Infant | 1 | 2021 | 30274 | 0.01 | Why? |
| Physicians | 1 | 2017 | 4214 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2019 | 8207 | 0.01 | Why? |
| Primary Health Care | 1 | 2015 | 4839 | 0.01 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.01 | Why? |
| United Kingdom | 1 | 2017 | 18046 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Animals | 1 | 2016 | 78931 | 0.00 | Why? |